Claim Missing Document
Check
Articles

Found 2 Documents
Search

Penyuluhan Beyond Use Date (BUD) Sediaan Farmasi Sebagai Upaya Meningkatkan Kualitas Penyimpanan Obat di Wairkoja, Maumere Kurniawati, Nelly; D, Masni; Lameng, Abraham Christian Mac.Arthur; Lameng, Fransiskus Xaverius; Jemading, Tarsisius; Mogi, Agustina
Jurnal Mandala Pengabdian Masyarakat Vol. 6 No. 2 (2025): Jurnal Mandala Pengabdian Masyarakat
Publisher : Progran Studi Farmasi Universitas Mandala Waluya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35311/jmpm.v6i2.611

Abstract

Pengetahuan masyarakat mengenai masa simpan sediaan farmasi (obat dan kosmetik) pasca pembukaan kemasan masih rendah, berpotensi menimbulkan risiko kesehatan. Kegiatan pengabdian ini bertujuan untuk meningkatkan pengetahuan masyarakat Desa Wairkoja tentang Beyond Use Date (BUD), expiry after opening, dan Period After Opening (PAO). Metode yang digunakan ialah penyuluhan interaktif disertai demonstrasi langsung menggunakan peraga obat dan kosmetik. Evaluasi dilakukan melalui pre-test dan post-test dengan kuesioner 12 item pada 34 peserta yang didominasi oleh perempuan (88%) dan ibu rumah tangga (71%) dengan tingkat pendidikan menengah (65%). Analisis data menggunakan uji Wilcoxon Signed-Rank dan uji McNemar.  Sebelum penyuluhan, 94% peserta memiliki pengetahuan rendah dengan skor rata-rata 30,4 ± 15,3. Setelah penyuluhan, terjadi peningkatan signifikan (p=0,001) dimana 100% peserta mencapai pengetahuan tinggi dengan skor rata-rata 93,6 ± 12,2. Peningkatan jawaban benar terjadi pada semua aspek, terutama pada pengetahuan masa simpan obat tetes mata, sirup kering, dan kosmetik dari 0% menjadi 94%. Penyuluhan interaktif yang dikombinasikan dengan demonstrasi alat peraga terbukti efektif secara signifikan dalam meningkatkan pengetahuan masyarakat tentang masa simpan sediaan farmasi pasca pembukaan kemasan.
High Prevalence of Potentially Inappropriate Medications among Geriatric Cardiovascular Patients: A Cross-Sectional Study at a Hospital in Eastern Indonesia Kurniawati, Nelly; D, Masni; Rahayu, Sri; Sola, Oktaviano Mariano Alberthino
MEDFARM: Jurnal Farmasi dan Kesehatan Vol 14 No 2 (2025): Medfarm: Jurnal Farmasi dan Kesehatan
Publisher : LPPM Akafarma Sunan Giri Ponorogo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.48191/medfarm.v14i2.675

Abstract

Potentially Inappropriate Medications (PIMs) are a frequent concern among elderly patients with cardiovascular disease (CVD), where polypharmacy and age-related vulnerability increase the risk of adverse outcomes. This study investigated the prevalence and contributing factors of PIMs in elderly CVD patients at dr. TC Hillers Hospital, Maumere, Indonesia. Both the 2023 American Geriatrics Society (AGS) Beers Criteria and the Screening Tool of Older Persons’ Prescriptions (STOPP) version 3 were applied to assess PIMs . A hospital based cross sectional design was implemented from August to September 2023, enrolling outpatients aged 65 years and above with confirmed CVD diagnose. Data regarding sociodemographic characteristics, comorbidities, and medications were collected from medical records. Among 110 patients, 141 PIM events (18.1%) were identified from 779 medications using Beers 2023, and 168 PIM events (21.6%) using STOPP v3. Chi-square test was used to examine differences in the prevalence of PIMs across demographic and clinical characteristics. The overall patient level prevalence of PIMs was 71% based on Beers 2023 and 68% based on STOPP v3. Polypharmacy was the strongest determinant, even in the absence of comorbidities. A higher Age-Adjusted Charlson Comorbidity Index (ACCI) scores showed no significant association with PIMs when using Beers 2023, but was significantly with STOPP v3. No significant associations were found with age or gender. Proton pump inhibitors, diuretics, and the combination of spironolactone with RAS inhibitors were the most frequent PIMs. In conclusion, PIM prevalence among elderly CVD outpatients in Maumere is alarmingly high, reflecting the complexity of cardiovascular pharmacotherapy.